Dianthus Therapeutics, Inc. (DNTH)
79.22
+1.22
(+1.56%)
USD |
NASDAQ |
Mar 17, 14:05
Dianthus Therapeutics Total Liabilities (Quarterly) : 38.00M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Daré Bioscience, Inc. | 27.89M |
| Relmada Therapeutics, Inc. | 5.411M |
| Ocugen, Inc. | 56.46M |
| Cartesian Therapeutics, Inc. | 422.65M |
| Stoke Therapeutics, Inc. | 52.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 531.40M |
| Shareholders Equity (Quarterly) | 493.40M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | -0.01% |